Inactivating PAPSS2 mutations in a patient with premature pubarche.
暂无分享,去创建一个
N. Hanley | J. Smeitink | R. Smeets | C. Noordam | N. Krone | W. Arlt | V. Dhir | F. Sweep | Joanne C. McNelis | H. Claahsen-van der Grinten | F. Schlereth
[1] B. Zabel,et al. Expression profile of Papss2 (3′‐phosphoadenosine 5′‐phosphosulfate synthase 2) during cartilage formation and skeletal development in the mouse embryo , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.
[2] R. Norman,et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. , 2006, The Journal of clinical endocrinology and metabolism.
[3] M. McCarthy,et al. Obesity and polycystic ovary syndrome , 2006, Clinical endocrinology.
[4] S. Witchel. Puberty and polycystic ovary syndrome , 2006, Molecular and Cellular Endocrinology.
[5] M. Goodarzi,et al. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. , 2006, Best practice & research. Clinical endocrinology & metabolism.
[6] David I. Wilson,et al. In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. , 2006, The Journal of clinical investigation.
[7] B. Allolio,et al. No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: in vivo and in vitro studies. , 2005, The Journal of clinical endocrinology and metabolism.
[8] J. L. San Millán,et al. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. , 2005, Endocrine reviews.
[9] A. Scheidig,et al. The crystal structure of human PAPS synthetase 1 reveals asymmetry in substrate binding. , 2005, Journal of molecular biology.
[10] D. Ehrmann. Polycystic ovary syndrome. , 2004, The New England journal of medicine.
[11] S. Mundlos,et al. Loss of chondroitin 6-O-sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] C. Shackleton,et al. Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study , 2004, The Lancet.
[13] R. Auchus,et al. Adrenarche – physiology, biochemistry and human disease , 2004, Clinical endocrinology.
[14] P. Claman. Men at risk: occupation and male infertility. , 2004, Fertility and sterility.
[15] C. Strott. Sulfonation and molecular action. , 2002, Endocrine reviews.
[16] N. Javitt,et al. Mutational Analysis of Human Hydroxysteroid Sulfotransferase SULT2B1 Isoforms Reveals That Exon 1B of the SULT2B1 Gene Produces Cholesterol Sulfotransferase, whereas Exon 1A Yields Pregnenolone Sulfotransferase* , 2002, The Journal of Biological Chemistry.
[17] Y. C. Lee,et al. Characterization and expression of human bifunctional 3'-phosphoadenosine 5'-phosphosulphate synthase isoforms. , 2002, The Biochemical journal.
[18] R. Weinshilboum,et al. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 2 (PAPSS2) pharmacogenetics: gene resequencing, genetic polymorphisms and functional characterization of variant allozymes. , 2002, Pharmacogenetics.
[19] L. Ibáñez,et al. Premature adrenarche--normal variant or forerunner of adult disease? , 2000, Endocrine reviews.
[20] D. Dewailly,et al. [Polycystic ovary syndrome]. , 2000, Journal de gynecologie, obstetrique et biologie de la reproduction.
[21] F. Amalric,et al. Nuclear localization of PAPS synthetase 1: a sulfate activation pathway in the nucleus of eukaryotic cells , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[22] M. Bidlingmaier,et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. , 1999, The New England journal of medicine.
[23] R. Cantor,et al. Mutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse , 1998, Nature Genetics.
[24] D. Rimoin,et al. Distinct, autosomal recessive form of spondyloepimetaphyseal dysplasia segregating in an inbred Pakistani kindred. , 1998, American journal of medical genetics.
[25] M. Warman,et al. A member of a family of sulfate-activating enzymes causes murine brachymorphism. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] B. Allolio,et al. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. , 1998, The Journal of clinical endocrinology and metabolism.
[27] B. Cockburn,et al. Deletion and Site-directed Mutagenesis of the ATP-binding Motif (P-loop) in the Bifunctional Murine Atp-Sulfurylase/Adenosine 5′-Phosphosulfate Kinase Enzyme* , 1998, The Journal of Biological Chemistry.
[28] T. Benraad,et al. Concentrations of total and free dehydroepiandrosterone in plasma and dehydroepiandrosterone in saliva of normal and hirsute women under basal conditions and during administration of dexamethasone/synthetic corticotropin. , 1990, Clinical chemistry.